Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents

被引:42
作者
Douglas, SD
Rudy, B
Muenz, L
Moscicki, AB
Wilson, CM
Holland, C
Crowley-Nowick, P
Vermund, SH
机构
[1] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[2] Westat Corp, Bethesda, MD USA
[3] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA
[4] Univ Alabama Birmingham, Dept Epidemiol & Int Hlth, Birmingham, AL USA
[5] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[6] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA
[7] Childrens Hosp, Natl Med Ctr, Washington, DC 20010 USA
[8] Harvard Univ, Brigham & Womens Hosp, Sch Med, Fearing Res Lab, Cambridge, MA 02138 USA
关键词
surface markers; adolescents; antiretroviral naive; high-risk adolescents; lymphocyte subsets;
D O I
10.1097/00002030-199909100-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To examine potential hematologic: and immunologic markers for healthy adolescents and for adolescents infected with HIV. Design: The REACH Project (Reaching for Excellence in Adolescent Care and Health) of the Adolescent Medicine HIV/AIDS Research Network (AMHARN) recruits HIV-infected and high-risk HIV-uninfected adolescents, aged at least 13 but less than 19 years. The study evaluates biomedical and behavioral features of HIV infection as observed while under medical care for HIV infection and adolescent health. Methods: Blood samples were collected from HIV-infected and HIV-uninfected subjects at 16 clinical sites. Cell phenotypes were determined using standard single, dual or three-color flow cytometry. Results: This report includes data at enrollment for 94 HIV-positive adolescents who had never received antiretroviral therapy (ART) (mean age, 17.4 +/- 1.0 years for males and 16.5 +/- 1.3 years for females) and; 149 HIV-negative adolescents (mean age, 16.7 +/- 1.2 years for males and 16.6 +/- 1.2 years for females); this is the antiretroviral therapy-naive subset drawn from 294 HIV-positive and 149 HIV-negative adolescents enrolled in the REACH Cohort. The total leukocyte count was significantly reduced in the HIV-positive females in comparison with the HIV-negative females (P < 0.001). There was a reduction in natural killer cells (P < 0.05) in HIV-positive females (mean, 140.6 +/- 104.2 x 10(6) cells/l) in comparison with HIV-negative females (184.3 +/- 142.5 x 10(6) cells/l), whereas no differences were found between the two groups of males. The reduction in the total CD4 cell count in HIV-positive males and females in comparison with the HIV-negative subjects was the consequence of a decrease in both the naive CD4 and memory CD4 components. There was a striking increase in the mean number of CD8 memory cells in HIV-positive compared with HIV-negative adolescents, and a corresponding increase in the percentage of these cells. In contrast, naive CD8 cells were present in increased numbers but their percentage was decreased. Conclusions: These studies of adolescents provide normative data for high-risk healthy adolescents as well as baseline immunologic data for a cohort of ART-naive HIV-positive adolescents. This comparison suggests that this untreated, recently infected group had relatively intact immunologic parameters. (C) 1399 Lippincott Williams & Wilkins.
引用
收藏
页码:1629 / 1635
页数:7
相关论文
共 21 条
[1]   Immune function in healthy adolescents [J].
Bartlett, JA ;
Schleifer, SJ ;
Demetrikopoulos, MK ;
Delaney, BR ;
Shiflett, SC ;
Keller, SE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (01) :105-113
[2]   AGE-RELATED-CHANGES IN HUMAN BLOOD LYMPHOCYTE SUBPOPULATIONS [J].
ERKELLERYUKSEL, FM ;
DENEYS, V ;
YUKSEL, B ;
HANNET, I ;
HULSTAERT, F ;
HAMILTON, C ;
MACKINNON, H ;
STOKES, LT ;
MUNHYESHULI, V ;
VANLANGENDONCK, F ;
DEBRUYERE, M ;
BACH, BA ;
LYDYARD, PM .
JOURNAL OF PEDIATRICS, 1992, 120 (02) :216-222
[3]   Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users [J].
Galai, N ;
Margolick, JB ;
Astemborski, J ;
Vlahov, D .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 79 (02) :134-141
[4]   Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDS [J].
Gange, SJ ;
Munoz, A ;
Chmiel, JS ;
Donnenberg, AD ;
Kirstein, LM ;
Detels, R ;
Margolick, JB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10848-10853
[5]   T cell turnover in HIV-1 disease [J].
Hellerstein, MK ;
McCune, JM .
IMMUNITY, 1997, 7 (05) :583-589
[6]   AGE-RELATED-CHANGES IN HUMAN BLOOD LYMPHOCYTE SUBPOPULATIONS .2. VARYING KINETICS OF PERCENTAGE AND ABSOLUTE COUNT MEASUREMENTS [J].
HULSTAERT, F ;
HANNET, I ;
DENEYS, V ;
MUNHYESHULI, V ;
REICHERT, T ;
DEBRUYERE, M ;
STRAUSS, K .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 70 (02) :152-158
[7]   SUBPOPULATIONS OF T-CELLS AND B-CELLS IN PERINATALLY HIV-INFECTED AND NONINFECTED AGE-MATCHED CHILDREN COMPARED WITH THOSE IN ADULTS [J].
IBEGBU, C ;
SPIRA, TJ ;
NESHEIM, S ;
MENDEZ, H ;
LEE, F ;
POLLIOTTI, B ;
CABA, J ;
NAHMIAS, A .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 71 (01) :27-32
[8]   Thymic aging and T-cell regeneration [J].
Mackall, CL ;
Gress, RE .
IMMUNOLOGICAL REVIEWS, 1997, 160 :91-102
[9]   AGE, THYMOPOIESIS, AND CD4+ T-LYMPHOCYTE REGENERATION AFTER INTENSIVE CHEMOTHERAPY [J].
MACKALL, CL ;
FLEISHER, TA ;
BROWN, MR ;
ANDRICH, MP ;
CHEN, CC ;
FEUERSTEIN, IM ;
HOROWITZ, ME ;
MAGRATH, IT ;
SHAD, AT ;
STEINBERG, SM ;
WEXLER, LH ;
GRESS, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (03) :143-149
[10]   Distinctions between CD8(+) and CD4(+) T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy [J].
Mackall, CL ;
Fleisher, TA ;
Brown, MR ;
Andrich, MP ;
Chen, CC ;
Feuerstein, IM ;
Magrath, IT ;
Wexler, LH ;
Dimitrov, DS ;
Gress, RE .
BLOOD, 1997, 89 (10) :3700-3707